Autos, biopharma brace for potential return to 25% US duties
South Korea’s corporate sector grew wary on Tuesday after US President Donald Trump signaled plans to reimpose higher tariffs on Korean exports, including cars and biopharmaceuticals, raising duties to 25 percent from the 15 percent level agreed upon in bilateral talks last year.
Automakers, among the most vulnerable to a policy reversal, were quick to reassess the impact, after Trump said the tariff hike would take effect following what he described as a failure by the National Assembly to approve the agreeme
Continue Reading on The Korea Herald
This preview shows approximately 15% of the article. Read the full story on the publisher's website to support quality journalism.